By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Maxim Pharmaceuticals, Inc. 

8899 University Center Lane, Suite 400

San Diego  California  92122-1013  U.S.A.
Phone: 858-453-4040 Fax: 858-453-5005



Schering Corporation 

Celera Corporation  Collaboration to identify and develop novel small-molecule compounds that induce apoptosis, potential new therapies for certain cancers.


Mayne Group Limited 

Company News
EpiCept Corporation Resolves All Remaining Litigation Against Maxim Pharmaceuticals, Inc. (MAXM) 10/5/2006 11:55:36 AM
EpiCept Corporation Settles Maxim Pharmaceuticals, Inc. (MAXM) Securities Litigation 3/27/2006 10:49:14 AM
EpiCept Corporation To Update Unaudited Pro Forma Financial Statements Of Merger With Maxim Pharmaceuticals, Inc. (MAXM) 3/24/2006 11:12:21 AM
EpiCept Corporation Completes Merger With Maxim Pharmaceuticals, Inc. (MAXM) 1/5/2006 1:20:51 PM
EpiCept Corporation Completes Merger With Maxim Pharmaceuticals, Inc. (MAXM) 1/5/2006 11:15:20 AM
EpiCept Corporation And Maxim Pharmaceuticals, Inc. (MAXM) Announce Trading And Listing Mechanics Upon Closing Of The Merger 12/28/2005 11:26:04 AM
Stockholders Of Maxim Pharmaceuticals, Inc. (MAXM) Approve Merger Proposal 12/21/2005 11:48:36 AM
Maxim Pharmaceuticals, Inc. (MAXM) Reports Fiscal 2005 Financial Results 12/14/2005 12:28:04 PM
Maxim Pharmaceuticals, Inc. (MAXM) Announces Initiation Of New Apoptosis Screening Campaign And Publication Of Manuscript In Journal Of Medicinal Chemistry10/19/2005 5:13:16 PM
Maxim Pharmaceuticals, Inc. (MAXM) Issued Patent For Method Of Identifying Therapeutically Effective Immunosupressive Agents10/19/2005 5:13:13 PM